Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06448390

Exercise Training Study of Patients With Claudicatio Intermittens

Led by Norwegian University of Science and Technology · Updated on 2025-06-06

100

Participants Needed

14

Research Sites

104 weeks

Total Duration

On this page

Sponsors

N

Norwegian University of Science and Technology

Lead Sponsor

S

Sykehuset i Vestfold HF

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of the study is to evaluate whether walking capacity in patients with intermittent claudication is improved more by home-based 5+ exercise training than by current recommendations of daily walking.

CONDITIONS

Official Title

Exercise Training Study of Patients With Claudicatio Intermittens

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Pain in the calves after 300 m or less measured on a treadmill
  • Stable symptoms for 6 months or more
  • Calf pain disappears within 5 minutes after stopping walking
  • Ankle-Brachial index of 0.7 or lower at rest
  • Using statins and antiplatelet drugs for at least 3 months
  • Age over 18 years
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Pain in hips or other areas outside the calves while walking
  • Pain lasting more than 5 minutes after stopping walking
  • Impossible to compress arteries when measuring Ankle-Brachial index or ABI lower than 0.4
  • Using statins and antiplatelet drugs for less than 3 months
  • Symptoms lasting less than 6 months
  • Diabetes with HbA1c over 48 mmol/mol (6%)
  • Revascularization within the last 6 months
  • Calf pain after walking more than 300 m on a treadmill
  • Reduced ankle mobility
  • Reduced physical ability to perform treadmill test
  • Age less than 18 years
  • General health conditions impairing participation (including obesity, COPD, heart disease, arthrosis, inflammatory joint diseases)
  • No signed informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 14 locations

1

Ålesund Sykehus

Ålesund, Norway

Actively Recruiting

2

Haukeland University Hospital

Bergen, Norway

Actively Recruiting

3

Vestre Viken, Drammen sykehus

Drammen, Norway

Actively Recruiting

4

Sykehuset Østfold Kalnes

Grålum, Norway

Actively Recruiting

5

Sykehuset Innlandet HF

Hamar, Norway

Actively Recruiting

6

Sørlandet Sykehus HF Kristiansand

Kristiansand, Norway

Actively Recruiting

7

Ahus University Hospital

Oslo, Norway

Actively Recruiting

8

Oslo university Hospital

Oslo, Norway

Actively Recruiting

9

Stavanger University Hospital

Stavanger, Norway

Actively Recruiting

10

St Olavs University Hospital

Trondheim, Norway

Actively Recruiting

11

Sykehuset i Vestfold HF

Tønsberg, Norway

Actively Recruiting

12

Sahlgrenska University Hospital

Gothenburg, Sweden

Actively Recruiting

13

Linköping University Hiospital

Linköping, Sweden

Actively Recruiting

14

Karolinska Institute

Stockholm, Sweden

Actively Recruiting

Loading map...

Research Team

E

Erney Mattsson, Professor

CONTACT

J

Joakim Nordanstig, Professor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here